Advertisement

Staging Systems

  • F. G. Rocha
  • W. R. Jarnagin
Chapter

Abstract

Originally described by Altmeier [1] and Klatskin [2], hilar cholangiocarcinoma is an adenocarcinoma of the extrahepatic biliary tree arising from the main left or right hepatic ducts or their confluence. Along with distal bile duct cancer and intrahepatic cholangiocarcinoma, they comprise the spectrum of bile duct cancers that arise from the biliary epithelium. However, unlike those tumors, which can be usually be removed, respectively, with pancreaticoduodenectomy or liver resection alone, the surgical approach to hilar cholangiocarcinoma often combines bile duct resection with concomitant hepatectomy and/or portal vein resection due to the infiltrative nature of the disease. Therefore, a complete, margin-negative resection can be difficult to achieve.

Keywords

Bile Duct Hilar Cholangiocarcinoma Bile Duct Cancer Bile Duct Resection Portal Vein Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Altemeier WA, Gall EA, Zinninger MM, et al. Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg. 1957;75(3):450–60; discussion 460–1.PubMedCrossRefGoogle Scholar
  2. 2.
    Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38:241–56.PubMedCrossRefGoogle Scholar
  3. 3.
    Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250(2):210–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140(2):170–8.PubMedGoogle Scholar
  5. 5.
    Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998;227(1):70–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Pitt HA, Dooley WC, Yeo CJ, et al. Malignancies of the biliary tree. Curr Probl Surg. 1995;32(1):1–90.PubMedCrossRefGoogle Scholar
  7. 7.
    Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463–73; discussion 473–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215(1):31–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct ­cancer: high resectability rate and 5-year survival. Ann Surg. 1999;230(2):266–75.PubMedCrossRefGoogle Scholar
  10. 10.
    Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230(6):808–18; discussion 819.PubMedCrossRefGoogle Scholar
  11. 11.
    Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010;17(4):449–54.PubMedCrossRefGoogle Scholar
  12. 12.
    Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010;17(4):455–62.PubMedCrossRefGoogle Scholar
  13. 13.
    Miyazaki M, Kimura F, Shimizu H, et al. One hundred seven ­consecutive surgical resections for hilar cholangiocarcinoma of ­bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci. 2010;17(4):470–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Unno M, Katayose Y, Rikiyama T, et al. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17(4):463–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 6th ed. New York: Springer; 2002.Google Scholar
  16. 16.
    Fleming ID, American Joint Committee on Cancer, American Cancer Society, et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.Google Scholar
  17. 17.
    Hong SM, Kang GH, Lee HY, et al. Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases. Am J Surg Pathol. 2000;24(5):660–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Nishio H, Nagino M, Oda K, et al. TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg. 2005;390(4):319–27.PubMedCrossRefGoogle Scholar
  19. 19.
    Hong SM, Kim MJ, Pi DY, et al. Analysis of extrahepatic bile duct carcinomas according to the new American Joint Committee on cancer staging system focused on tumor classification problems in 222 patients. Cancer. 2005;104(4):802–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Hong SM, Cho H, Moskaluk CA, et al. Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol. 2007;31(2):199–206.PubMedCrossRefGoogle Scholar
  21. 21.
    Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238(5):720–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242(3):451–8; discussion 458–61.PubMedGoogle Scholar
  23. 23.
    Klempnauer J, Ridder GJ, von Wasielewski R, et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997;15(3):947–54.PubMedGoogle Scholar
  24. 24.
    Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233(3):385–92.PubMedCrossRefGoogle Scholar
  25. 25.
    Deki H, Sato T. An anatomic study of the peripancreatic lymphatics. Surg Radiol Anat. 1988;10(2):121–35.PubMedCrossRefGoogle Scholar
  26. 26.
    Shirai Y, Yoshida K, Tsukada K, et al. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992;79(7):659–62.PubMedCrossRefGoogle Scholar
  27. 27.
    Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908–14.PubMedCrossRefGoogle Scholar
  28. 28.
    House MG, Gonen M, Jarnagin WR, et al. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007;11(11):1549–55.PubMedCrossRefGoogle Scholar
  29. 29.
    Tepper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19(1):157–63.PubMedGoogle Scholar
  30. 30.
    Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. Population data. J Gastrointest Surg. 2007;11(2):158–65.PubMedCrossRefGoogle Scholar
  31. 31.
    Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg. 2010;251(4):675–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Hong SM, Cho H, Lee OJ, et al. The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol. 2005;29(9):1177–83.PubMedCrossRefGoogle Scholar
  33. 33.
    Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–66; discussion 366–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Kawai M, Tani M, Kobayashi Y, et al. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg. 2010;199(4):447–52.PubMedCrossRefGoogle Scholar
  35. 35.
    Oshiro Y, Sasaki R, Kobayashi A, et al. Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2011;37(1):60–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Sasaki R, Murata S, Oda T, et al. Evaluation of UICC-TNM and JSBS staging systems for surgical patients with extrahepatic cholangiocarcinoma. Langenbecks Arch Surg. 2010;395(6):615–23.PubMedCrossRefGoogle Scholar
  37. 37.
    Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241(5):703–12; discussion 712–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Gazzaniga GM, Faggioni A, Filauro M. Surgical treatment of proximal bile duct tumors. Int Surg. 1985;70(1):45–8.PubMedGoogle Scholar
  39. 39.
    Gazzaniga GM, Filauro M, Bagarolo C, et al. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg. 2000;7(2):122–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228(3):385–94.PubMedCrossRefGoogle Scholar
  41. 41.
    Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507–17; discussion 517–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Rocha FG, Matsuo K, Blumgart LH, et al. Hilar cholangiocarcinoma: the memorial sloan-kettering cancer center experience. J Hepatobiliary Pancreat Sci. 2010;17(4):490–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241(5):693–9; discussion 699–702.PubMedCrossRefGoogle Scholar
  44. 44.
    Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248(2):273–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Zervos EE, Osborne D, Goldin SB, et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg. 2005;190(5):810–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Blechacz BR, Sanchez W, Gores GJ. A conceptual proposal for staging ductal cholangiocarcinoma. Curr Opin Gastroenterol. 2009;25(3):238–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Weston BR, Ross WA, Wolff RA, et al. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer. 2008;112(11):2417–23.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht and People's Medical Publishing House 2013

Authors and Affiliations

  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Hepatopancreatobiliary Service, Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations